Growth Due Diligence

Understand the quality of growth before you invest in it.

Growth can look attractive while hiding unsustainable acquisition economics, measurement weaknesses or concentration risk. Boldscale examines growth quality for the people whose capital depends on it — with the perspective of operators who have scaled businesses themselves.

Written for

  • Private equity
  • Venture capital
  • Family offices
  • Acquirers
  • Investment committees
  • Corporate development
  • Founders preparing for diligence

What attractive growth can hide

  • Unsustainable CAC
  • Overstated LTV
  • Channel concentration
  • Paid-demand dependency
  • Weak retention
  • Attribution inflation
  • Creative concentration
  • Measurement weaknesses
  • Scaling limits

What Boldscale examines

Acquisition & economics

  • Customer acquisition economics
  • Normalised CAC
  • LTV assumptions
  • Paid vs organic demand

Quality & scalability

  • Retention and cohorts
  • Channel concentration
  • Growth scalability
  • Measurement quality
  • Commercial risks

Deliverables may include

  • Growth quality assessment
  • Acquisition economics review
  • Cohort and retention assessment
  • Channel dependency analysis
  • Measurement risk
  • Scalability risks
  • Material red flags
  • Upside opportunities
  • Investment committee summary

Scope of this service

Boldscale Growth Due Diligence is commercial and growth analysis. It is not regulated investment advice, a statutory financial audit or financial due diligence.

FAQ

  • Yes. Scope and depth are agreed to fit the transaction timeline and the questions the investment committee needs answered.

Know how far the growth can scale before you commit capital.

Discuss a growth diligence scope for your transaction.

Book a Growth Call

Results, figures and examples on this website are illustrative and do not guarantee future performance. Boldscale’s Performance Audit, Performance Monitoring and Growth Due Diligence services provide marketing, growth and commercial analysis; they are not statutory financial audits, accounting assurance, legal opinions, credit or investment ratings, or regulated investment advice.